Ved akut koronarsyndrom uden ST- elevation var den samlede relative mindskelse af risikoen for en hændelse 20% i forhold til placebo.
In non-ST elevation acute coronary syndrome, the overall relative reduction in the risk of an event compared to placebo was 20%.